Type I RTKs: ErbB (epidermal growth factor) receptor family in GtoPdb v.2025.3
DOI:
https://doi.org/10.2218/gtopdb/F320/2025.3Abstract
ErbB family receptors are Class I receptor tyrosine kinases [51]. EGFR (HER1) was the first member of the family to be identified. ERBB2 (also known as HER-2 or NEU) appears to act as an essential partner for the other members of the family without itself being activated by a cognate ligand [52]. Ligands of the ErbB family of receptors are peptides, many of which are generated by proteolytic cleavage of cell-surface proteins. HER/ErbB is the viral counterpart to the receptor tyrosine kinase EGFR. All family members heterodimerize with each other to activate downstream signalling pathways and are aberrantly expressed in many cancers, particularly forms of breast cancer and lung cancer. Mutations in the EGFR are responsible for acquired resistance to tyrosine kinase inhibitor chemotherapeutics.Downloads
Download data is not yet available.
Downloads
Published
10-Sep-2025
Issue
Section
Articles
License
Copyright (c) 2025 The authors

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
“Type I RTKs: ErbB (epidermal growth factor) receptor family in GtoPdb v.2025.3” (2025) IUPHAR/BPS Guide to Pharmacology CITE, 2025(3). doi:10.2218/gtopdb/F320/2025.3.




